Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma

被引：0
|
作者：
Taku Naiki
Noriyasu Kawai
Yoshihiro Hashimoto
Takehiko Okamura
Ryosuke Ando
Takahiro Yasui
Atsushi Okada
Toshiki Etani
Keiichi Tozawa
Kenjiro Kohri
机构：
[1] Nagoya City University,Department of Nephro
[2] Anjo Kosei Hospital,urology, Graduate School of Medical Sciences
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Metastasis; Urothelial carcinoma; Second-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：516 / 522
页数：6
相关论文
共 50 条
  • [1] Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma
    Naiki, Taku
    Kawai, Noriyasu
    Hashimoto, Yoshihiro
    Okamura, Takehiko
    Ando, Ryosuke
    Yasui, Takahiro
    Okada, Atsushi
    Etani, Toshiki
    Tozawa, Keiichi
    Kohri, Kenjiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 516 - 522
  • [2] Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis
    Naiki, Taku
    Iida, Keitaro
    Etani, Toshiki
    Nagai, Takashi
    Tanaka, Yutaro
    Sugiyama, Yosuke
    Ando, Ryosuke
    Hamamoto, Shuzo
    Banno, Rika
    Nagata, Daisuke
    Kawai, Noriyasu
    Yasui, Takahiro
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3669 - 3677
  • [3] Combination of Gemcitabine and Paclitaxel as Second-line Chemotherapy for Advanced Urothelial Carcinoma
    Suyama, Takahito
    Ueda, Takeshi
    Fukasawa, Satoshi
    Imamura, Yusuke
    Nakamura, Kazuyoshi
    Miyasaka, Kyoko
    Sazuka, Tomokazu
    Egoshi, Ken-ichi
    Nihei, Naoki
    Hamano, Masaaki
    Ichikawa, Tomohiko
    Maruoka, Masayuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (04) : 244 - 250
  • [4] Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma
    Matsumoto, Kazumasa
    Irie, Akira
    Satoh, Takefumi
    Okazaki, Miyoko
    Iwamura, Masatsugu
    Baba, Shiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (11) : 1000 - 1004
  • [5] Gemcitabine and Docetaxel Chemotherapy is a Favorable Treatment as a Second-Line Chemotherapy for Metastatic Urothelial Carcinoma After Failure of a Platinum-Based Regimen
    Naiki, T.
    Kawai, N.
    Okamura, T.
    Ando, R.
    Ikegami, Y.
    Etani, T.
    Tozawa, K.
    Kohri, K.
    UROLOGY, 2012, 80 (03) : S206 - S206
  • [6] Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?
    R. Morales-Barrera
    C. Suárez
    C. Valverde
    I. Nuñez
    X. Maldonado
    J. Morote
    J. Carles
    Clinical and Translational Oncology, 2014, 16 : 102 - 106
  • [7] Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?
    Morales-Barrera, R.
    Suarez, C.
    Valverde, C.
    Nunez, I.
    Maldonado, X.
    Morote, J.
    Carles, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (01): : 102 - 106
  • [8] Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma
    Oguri, T
    Achiwa, H
    Kato, D
    Maeda, H
    Niimi, T
    Sato, S
    Ueda, R
    CHEMOTHERAPY, 2004, 50 (06) : 279 - 282
  • [9] A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma
    Kim, Young Saing
    Lee, Soon Il
    Park, Se Hoon
    Park, Silvia
    Hwang, In Gyu
    Lee, Sang-Cheol
    Sun, Jong-Mu
    Lee, Jeeyun
    Lim, Ho Yeong
    CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : 76 - 81
  • [10] Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma -: Editorial comment
    Nakagawa, Masayuki
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (11) : 1004 - 1004
12345